Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 234,265,103 papers from all fields of science
Search
Sign In
Create Free Account
Macrophage Activation Syndrome
Known as:
MAS
, Macrophage Activation Syndrome [Disease/Finding]
, Reactive Hemophagocytic Lymphohistiocytosis
Expand
A complication of rheumatic disease that is caused by excessive activation and uncontrolled proliferation of T lymphocytes and well-differentiated…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
9 relations
Histiocytosis, Non-Langerhans-Cell
Immune System Diseases
In Blood
Microbiological
Expand
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
AB0266 Effects of periodontal basic treatment on periodontal condition, clinical response and serum inflammatory parameters in rheumatoid arthritis (RA) patients with moderate to severe periodontitis
F. Xiao
,
P. Zhang
,
Xiaodi Li
,
Y. Mou
,
H. Chen
,
Y. Cai
Abstracts Accepted for Publication
2017
Corpus ID: 79635550
Background Periodontal disease (PD) shares several clinical and pathogenic characteristics with Rheumatoid Arthritis (RA). Some…
Expand
2016
2016
Alleviating the storm: ruxolitinib in HLH
2016
Corpus ID: 206944494
They used genetically engineered perforindeficient Prf1 mice as a model of familial HLH with impaired adaptive immunity due to…
Expand
2014
2014
Systemic Adverse Events with Biomedicines
G. Tridente
2014
Corpus ID: 29772652
The core of biological agents recently introduced in human therapy includes Monoclonal Antibodies, Fusion proteins and a number…
Expand
Review
2012
Review
2012
Toward the Development of New Diagnostic Criteria for Macrophage Activation Syndrome in Systemic Juvenile Idiopathic Arthritis
S. Davì
,
B. Lattanzi
,
+7 authors
A. Ravelli
2012
Corpus ID: 73057927
Macrophage activation syndrome (MAS) is a severe, potentially fatal complication of systemic juvenile idiopathic arthritis (sJIA…
Expand
2011
2011
MACROPHAGE ACTIVATION SYNDROME IN TWO GIRLS WITH SYSTEMIC LUPUS ERYTHEMATOSUS
N. Iagăru
,
D. Orășeanu
,
F. Rusu
,
M. Luminos
,
A. Drăgănescu
,
A. Ghiţă
2011
Corpus ID: 46521395
Background: Most frequently seen in Systemic Arthritis – Juvenile Idiopathic Arthritis, macrophage activation syndrome (MAS) may…
Expand
2008
2008
Remembering other causes of alveolar siderophages: macrophage activation syndrome.
A. Santana
,
R. Kairalla
,
C. Carvalho
Chest
2008
Corpus ID: 42759703
2008;133;1055 Chest Alfredo N. C. Santana, Ronaldo A. Kairalla and Carlos R. R. Carvalho Syndrome Siderophages : Macrophage…
Expand
2007
2007
Infectious causes of macrophage activation syndrome.
PR Acharya
Journal of Association of Physicians of India
2007
Corpus ID: 45319507
www.japi.org 877 either endogenous reactivation of TB or predisposed our patient to exogenous reinfection. The extension of the…
Expand
2001
2001
Nocardiose thoracique associée à un syndrome d'activation macrophagique
F. Simon
,
J. Koninck
,
+7 authors
P. L’her
2001
Corpus ID: 76805226
La nocardiose est une affection bacterienne rare, survenant preferentiellement chez des individus immunodeprimes. Ses…
Expand
1997
1997
Transient multiple cranial nerve involvement as a first sign of macrophage activation syndrome.
L. Rumbach
,
E. Berger
,
+4 authors
F. Schillinger
Journal of Neurology Neurosurgery & Psychiatry
1997
Corpus ID: 46041337
malities; in particular there was no arachnoid cyst. Consequently, a third blood patch (20 ml) was carried out at a higher level…
Expand
1997
1997
Makrophagenaktivierungssyndrom (MAS) Eine ernste Komplikation bei Kindern mit rheumatischen Erkrankungen
R. Morhart
,
H. Truckenbrodt
Monatsschrift Kinderheilkunde
1997
Corpus ID: 43818270
ZusammenfassungDas MAS stellt eine wenig bekannte Komplikation bei rheumakranken Kinder dar. Es tritt zwar selten auf, kommt…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE